Image Credit: Getty Images

Treating people who have early memory problems with Alzheimer’s drugs seems to have no affect on the onslaught of the disease, researchers said Tuesday. Three main drugs — Aricept, or donepezil; Exelon, or rivastigmine; and Reminyl, or galantamine — are currently approved for use in mild-to-moderate Alzheimer’s disease. They are also often prescribed on a so-called “off-label” basis to people with pre-dementia. [continue reading…]